Christian Bayerl

Christian Bayerl

Auto-generated profile, based on publicly available information

Christian Bayerl

Charité - Universitätsmedizin Berlin

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
RRRolf Reiter
Rolf Reiter
MSMehrgan Shahryari
Mehrgan Shahryari
HTHeiko Tzschätzsch
Heiko Tzschätzsch
MHMatthias Haas
Matthias Haas
CBChristian Bayerl
Christian Bayerl
ISIngolf Sack
Ingolf Sack

5 February 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CBChristian Bayerl
Christian Bayerl
RLRoberto Lorbeer
Roberto Lorbeer
MHMargit Heier
Margit Heier
CMChrista Meisinger
Christa Meisinger
SRSusanne Rospleszcz
Susanne Rospleszcz
HHHolger Hetterich
Holger Hetterich
The aim of our study was to determine the relation of alcohol consumption and cigarette smoking on continuous-measured hepatic fat fraction (HFF) in a population free of cardiovascular disease. We suggested a direct correlation of alcohol consumption with HFF and increased HFF in former smokers compared to current smokers. Data from 384 subjects (mean age: 56 years, 58% men) of a population-based cohort study (KORA) were included in a cross-sectional design. Liver fat was assessed by 3 Tesla magnetic resonance imaging (MRI) using a multi-echo Dixon sequence and T2-corrected single voxel multi-echo spectroscopy (1H-MRS). Smoking status was classified as never, former or current smoker and alcohol consumption as non-, moderate (0.1–39.9 g/day for men and 0.1–19.9 g/day for women), or heavy drinker (≥ 40 g/day for men and ≥ 20 g/day for women). Fatty liver disease was defined as HFF≥5.56%. Average HFF was 8.8% by 1H-MRS and 8.5% by MRI. Former smokers showed a higher HFF (MRI: β = 2.64; p = 0.006) and a higher FLD prevalence (MRI: OR = 1.91; p = 0.006) compared to never smokers. Current smokers showed decreased odds for FLD measured by 1H-MRS after multivariable adjustment (OR = 0.37; p = 0.007) with never smoker as reference. Heavy drinking was positively associated with HFF (1H-MRS: β = 2.99; p = 0.003) and showed highest odds for FLD (1H-MRS: OR = 3.05; p = 0.008) with non-drinker as reference. Moderate drinking showed a positive association with HFF (1H-MRS: β = 1.54; p = 0.061 and MRI: β = 1.75; p = 0.050). Our data revealed lowest odds for FLD in current smokers, moderate drinkers showing higher HFF than non-drinkers and heavy drinkers showing highest HFF and odds for FLD. These findings partly conflict with former literature and underline the importance of further studies to investigate the complex effects on liver metabolism.

3 September 2024 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Open access
CBChristian Bayerl
Christian Bayerl
YSYasmine Safraou
Yasmine Safraou
RRRolf Reiter
Rolf Reiter
VPVanessa Proß
Vanessa Proß
KLKai Lehmann
Kai Lehmann
PAPatrick Asbach
Patrick Asbach
To study the potential of viscoelastic parameters such as liver stiffness, loss tangent (marker of viscous properties) and viscoelastic dispersion to detect hepatic inflammation by in-vivo and ex-vivo MR elastography (MRE) at low and high vibration frequencies. 15 patients scheduled for liver tumor resection surgery were prospectively enrolled in this IRB-approved study and underwent multifrequency in-vivo MRE (30-60Hz) at 1.5-T prior to surgery. Immediately after liver resection, tumor-free tissue specimens were examined with ex-vivo MRE (0.8-2.8 kHz) at 0.5-T and histopathologic analysis including NAFLD activity score (NAS) and inflammation score (I-score) as sum of histological sub-features of inflammation. In-vivo, in regions where tissue samples were obtained, the loss tangent correlated with the I-score (R = 0.728; p = 0.002) and c-dispersion (stiffness dispersion over frequency) correlated with lobular inflammation (R = -0.559; p = 0.030). In a subgroup of patients without prior chemotherapy, c-dispersion correlated with I-score also in the whole liver (R = -0.682; p = 0.043). ROC analysis of the loss tangent for predicting the I-score showed a high AUC for I ≥ 1 (0.944; p = 0.021), I ≥ 2 (0.804; p = 0.049) and I ≥ 3 (0.944; p = 0.021). Ex-vivo MRE was not sensitive to inflammation, whereas strong correlations were observed between fibrosis and stiffness (R = 0.589; p = 0.021), penetration rate (R = 0.589; p = 0.021), loss tangent (R = -0.629; p = 0.012), and viscoelastic model parameters (spring-pot powerlaw exponent, R = -0.528; p = 0.043; spring-pot shear modulus, R = 0.589; p = 0.021). Our results suggest that c-dispersion of the liver is sensitive to inflammation when measured in-vivo in the low dynamic range (30-60Hz), while at higher frequencies (0.8-2.8 kHz) viscoelastic parameters are dominated by fibrosis.

15 December 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
VPVanessa Proß
Vanessa Proß
ASArne Sattler
Arne Sattler
SLSören Lukassen
Sören Lukassen
LTLaura Tóth
Laura Tóth
LTLinda Marie Laura Thole
Linda Marie Laura Thole
KKKatja Kotsch
Katja Kotsch
Tissue-resident lymphocytes provide organ-adapted protection against invading pathogens. Whereas their biology has been examined in great detail in various infection models, their generation and functionality in response to vaccination have not been comprehensively analyzed in humans. We therefore studied SARS-CoV-2 mRNA vaccine–specific T cells in surgery specimens of kidney, liver, lung, bone marrow, and spleen compared with paired blood samples from largely virus-naive individuals. As opposed to lymphoid tissues, nonlymphoid organs harbored significantly elevated frequencies of spike-specific CD4+ T cells compared with blood showing hallmarks of tissue residency and an expanded memory pool. Organ-derived CD4+ T cells further exhibited increased polyfunctionality over those detected in blood. Single-cell RNA-Seq together with T cell receptor repertoire analysis indicated that the clonotype rather than organ origin is a major determinant of transcriptomic state in vaccine-specific CD4+ T cells. In summary, our data demonstrate that SARS-CoV-2 vaccination entails acquisition of tissue memory and residency features in organs distant from the inoculation site, thereby contributing to our understanding of how local tissue protection might be accomplished.

14 August 2025 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
CBChristian Bayerl
Christian Bayerl
JKJonas Kaufmann
Jonas Kaufmann
GMGiulia Metzger
Giulia Metzger
JRJulian M. M. Rogasch
Julian M. M. Rogasch
HAHolger Amthauer
Holger Amthauer
CFChristian Furth
Christian Furth
Purpose: Retroperitoneal fibrosis (RPF) is a rare inflammatory disease, that, if left untreated, can lead to ureteral obstruction and subsequent renal impairment. First-line treatment is prednisolone, with rituximab, often used for refractory cases. This study evaluates treatment response in both [ 18 F]FDG PET and CT, and potential baseline parameters for early prediction of progression. Methods: 50 patients with RPF underwent at least two [ 18 F]FDG PET/CT scans (baseline, BL, and first follow-up, FU1), 36 patients a second (FU2), 18 patients a third follow-up (FU3). PET parameters SUV max , SUV mean , SUV peak , metabolic active volume (MAV), thickness (CT rim ) and cranio-caudal extension (CT cc ) of the retroperitoneal mass were measured. Therapy groups were divided into prednisolone, rituximab and the combination of both. Results: All PET parameters showed significant correlations with CT rim at all four timepoints. After therapy all PET parameters and CT rim decreased significantly ( p ≤ 0.021). Highly significant metabolic and morphologic response was seen in the prednisolone ( p ≤ 0.003) and the combination therapy group ( p ≤ 0.001). At FU2, eight patients showed progression, with MAV as a good predictor of progression in BL ( p = 0.041; 217.33 versus 100.86 ml). At FU2, SUV max , SUV peak and MAV differed significantly between progression and non-progression group ( p ≤ 0.009), while CT showed no significant differences. Conclusion: Our findings underscore the superiority of PET against CT in therapy monitoring of RPF, especially in the detection of progression at FU2. Higher BL MAV correlated with progression at FU2, indicating its potential as a predictive marker. Still, especially when PET is not available, CT can be considered for initial therapy monitoring.

11 November 2025 in Investigative Radiology
Verified
Journal Article
Open access
CBChristian Bayerl
Christian Bayerl
MSMehrgan Shahryari
Mehrgan Shahryari
RRRolf Reiter
Rolf Reiter
VPVanessa Proß
Vanessa Proß
KLKai Lehmann
Kai Lehmann
PAPatrick Asbach
Patrick Asbach
Objectives: Gadolinium-based contrast agents (GBCAs) are widely used in magnetic resonance imaging. Concerns exist regarding gadolinium deposition and its potential histopathologic tissue alterations, especially after repeated administrations of linear, less stable GBCAs. This study aimed to quantify gadolinium mass fractions in liver specimens of subjects exposed to GBCAs in correlation with histopathologic features. Materials and Methods: In this Institutional Review Board–approved study, mass fractions of gadolinium in human liver specimens ω(Gd) from 25 subjects who underwent liver tumor resection surgery and had received GBCA (1 to 9 times over 4 y), were quantitatively analyzed using inductively coupled plasma–mass spectrometry (ICP-MS). Histomorphology was assessed based on the nonalcoholic fatty liver disease activity score (NAS). Linear regression analyses were performed with ω(Gd), time and dosage metrics, and histopathologic parameters. Results: The median interval between last GBCA administration and surgery (T) was 14 days (range: 1 to 69 d). Gadolinium was detected in all liver samples (ω(Gd), median: 0.348 µg/g; range: 0.120 to 0.874 µg/g). No significant correlation was found between ω(Gd) and histologic scores, including inflammation and fibrosis. A strong negative correlation was found between ω(Gd) and ln(T) ( P < 0.001). A positive correlation existed between ω(Gd) and the number ( P = 0.010) but not the cumulative dose of previous GBCA administrations ( P = 0.205). Conclusions: Our results suggest that after intravenous administration of GBCA, a small fraction of gadolinium is retained in the liver over a time period of at least several weeks. A relationship was observed between Gadolinium retention and the number of GBCA administrations, but not with the cumulative dose and the degree of fatty liver disease.